Cite
HARVARD Citation
Kerlin, B. et al. (2017). Recombinant factor XIII prophylaxis is safe and effective in young children with congenital factor XIII‐A deficiency: international phase 3b trial results. Journal of thrombosis and haemostasis. pp. 1601-1606. [Online].